Process engineering of human pluripotent stem cells for clinical application

Research output: Contribution to journalArticlepeer-review

187 Citations (Scopus)


Human pluripotent stem cells (hPSCs), including embryonic and induced pluripotent stem cells, constitute an extremely attractive tool for cell therapy. However, flexible platforms for the large-scale production and storage of hPSCs in tightly controlled conditions are necessary to deliver high-quality cells in relevant quantities to satisfy clinical demands. Here we discuss the main principles for the bioprocessing of hPSCs, highlighting the impact of environmental factors, novel 3D culturing approaches and integrated bioreactor strategies for controlling hPSC culture outcome. Knowledge on hPSC bioprocessing accumulated during recent years provides important insights for the establishment of more robust production platforms and should potentiate the implementation of novel hPSC-based therapies.
Original languageUnknown
Pages (from-to)350-359
JournalTrends In Biotechnology
Issue number6
Publication statusPublished - 1 Jan 2012

Cite this